These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 31142317

  • 1. Transmembrane-4 L-six family member-1 (TM4SF1) promotes non-small cell lung cancer proliferation, invasion and chemo-resistance through regulating the DDR1/Akt/ERK-mTOR axis.
    Ye L, Pu C, Tang J, Wang Y, Wang C, Qiu Z, Xiang T, Zhang Y, Peng W.
    Respir Res; 2019 May 29; 20(1):106. PubMed ID: 31142317
    [Abstract] [Full Text] [Related]

  • 2. FAM83D promotes epithelial-mesenchymal transition, invasion and cisplatin resistance through regulating the AKT/mTOR pathway in non-small-cell lung cancer.
    Yin C, Lin X, Wang Y, Liu X, Xiao Y, Liu J, Snijders AM, Wei G, Mao JH, Zhang P.
    Cell Oncol (Dordr); 2020 Jun 29; 43(3):395-407. PubMed ID: 32006253
    [Abstract] [Full Text] [Related]

  • 3. TM4SF1 Promotes Metastasis of Pancreatic Cancer via Regulating the Expression of DDR1.
    Yang JC, Zhang Y, He SJ, Li MM, Cai XL, Wang H, Xu LM, Cao J.
    Sci Rep; 2017 Apr 03; 7():45895. PubMed ID: 28368050
    [Abstract] [Full Text] [Related]

  • 4. TM4SF1 facilitates non-small cell lung cancer progression through regulating YAP-TEAD pathway.
    Fu XY, Zhou WB, Xu J.
    Eur Rev Med Pharmacol Sci; 2020 Feb 03; 24(4):1829-1840. PubMed ID: 32141552
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hydroxysafflor yellow A inhibited lipopolysaccharide-induced non-small cell lung cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT/mTOR and ERK/MAPK signaling pathways.
    Jiang M, Zhou LY, Xu N, An Q.
    Thorac Cancer; 2019 Jun 03; 10(6):1319-1333. PubMed ID: 31055884
    [Abstract] [Full Text] [Related]

  • 7. A Ferulic Acid Derivative FXS-3 Inhibits Proliferation and Metastasis of Human Lung Cancer A549 Cells via Positive JNK Signaling Pathway and Negative ERK/p38, AKT/mTOR and MEK/ERK Signaling Pathways.
    Yue SJ, Zhang PX, Zhu Y, Li NG, Chen YY, Li JJ, Zhang S, Jin RY, Yan H, Shi XQ, Tang YP, Duan JA.
    Molecules; 2019 Jun 08; 24(11):. PubMed ID: 31181779
    [Abstract] [Full Text] [Related]

  • 8. Role of TM4SF1 in regulating breast cancer cell migration and apoptosis through PI3K/AKT/mTOR pathway.
    Sun Y, Xu Y, Xu J, Lu D, Wang J.
    Int J Clin Exp Pathol; 2015 Jun 08; 8(8):9081-8. PubMed ID: 26464650
    [Abstract] [Full Text] [Related]

  • 9. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.
    Shi H, Pu J, Zhou XL, Ning YY, Bai C.
    Tumour Biol; 2017 May 08; 39(5):1010428317697568. PubMed ID: 28459375
    [Abstract] [Full Text] [Related]

  • 10. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y, Li S, Li J, Wang D, Li Q.
    Cell Physiol Biochem; 2017 May 08; 42(4):1431-1446. PubMed ID: 28715819
    [Abstract] [Full Text] [Related]

  • 11. Silencing the FOLR2 Gene Inhibits Cell Proliferation and Increases Apoptosis in the NCI-H1650 Non-Small Cell Lung Cancer Cell Line via Inhibition of AKT/Mammalian Target of Rapamycin (mTOR)/Ribosomal Protein S6 Kinase 1 (S6K1) Signaling.
    Xu X, Jiang J, Yao L, Ji B.
    Med Sci Monit; 2018 Nov 11; 24():8064-8073. PubMed ID: 30415267
    [Abstract] [Full Text] [Related]

  • 12. TM4SF1 involves in miR-1-3p/miR-214-5p-mediated inhibition of the migration and proliferation in keloid by regulating AKT/ERK signaling.
    Xu M, Sun J, Yu Y, Pang Q, Lin X, Barakat M, Lei R, Xu J.
    Life Sci; 2020 Aug 01; 254():117746. PubMed ID: 32376266
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. MiRNA-206 suppresses PGE2-induced colorectal cancer cell proliferation, migration, and invasion by targetting TM4SF1.
    Park YR, Seo SY, Kim SL, Zhu SM, Chun S, Oh JM, Lee MR, Kim SH, Kim IH, Lee SO, Lee ST, Kim SW.
    Biosci Rep; 2018 Oct 31; 38(5):. PubMed ID: 30135139
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. TAZ inhibition restores sensitivity of cisplatin via AKT/mTOR signaling in lung adenocarcinoma.
    Xu W, Wei Y, Li Y, Yin Y, Yuan W, Yang Y, Zhao W, Wu J.
    Oncol Rep; 2017 Sep 31; 38(3):1815-1821. PubMed ID: 28737828
    [Abstract] [Full Text] [Related]

  • 17. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.
    Fu QF, Liu Y, Fan Y, Hua SN, Qu HY, Dong SW, Li RL, Zhao MY, Zhen Y, Yu XL, Chen YY, Luo RC, Li R, Li LB, Deng XJ, Fang WY, Liu Z, Song X.
    J Hematol Oncol; 2015 Mar 08; 8():22. PubMed ID: 25887760
    [Abstract] [Full Text] [Related]

  • 18. FKBP4 Accelerates Malignant Progression of Non-Small-Cell Lung Cancer by Activating the Akt/mTOR Signaling Pathway.
    Meng W, Meng J, Jiang H, Feng X, Wei D, Ding Q.
    Anal Cell Pathol (Amst); 2020 Mar 08; 2020():6021602. PubMed ID: 33354489
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prostaglandin transporter, SLCO2A1, mediates the invasion and apoptosis of lung cancer cells via PI3K/AKT/mTOR pathway.
    Zhu Q, Liang X, Dai J, Guan X.
    Int J Clin Exp Pathol; 2015 Mar 08; 8(8):9175-81. PubMed ID: 26464663
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.